Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Saa2 (serum amyloid A 2) Mus musculus
Analyze
Symbol: Saa2
Name: serum amyloid A 2
RGD ID: 1618412
Description: Predicted to have G protein-coupled receptor binding activity and chemoattractant activity. Involved in response to stilbenoid. Predicted to localize to cytoplasmic microtubule and extracellular space. Is expressed in liver. Orthologous to human SAA1 (serum amyloid A1); INTERACTS WITH 1,2-dimethylhydrazine; 1-naphthyl isothiocyanate; 2,2',4,4',5,5'-hexachlorobiphenyl.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: AW111173; Sa; Saa-2; Saa1; serum amyloid A 1; serum amyloid A-2 protein
Orthologs:
Homo sapiens (human) : SAA2 (serum amyloid A2)  HGNC  Alliance
Pan paniscus (bonobo/pygmy chimpanzee) : SAA2 (serum amyloid A2)
Sus scrofa (pig) : SAA2 (serum amyloid A-2 protein)
more info ...
Latest Assembly: GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm38.p6 Ensembl746,751,790 - 46,754,313 (+)EnsemblGRCm38mm10GRCm38
GRCm38746,751,833 - 46,754,313 (+)NCBIGRCm38GRCm38mm10GRCm38
MGSCv37754,007,203 - 54,009,684 (+)NCBIGRCm37mm9NCBIm37
MGSCv36746,619,875 - 46,622,354 (+)NCBImm8
Celera742,226,060 - 42,228,543 (+)NCBICelera
Cytogenetic Map7B3NCBI
cM Map730.56NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Phenotype Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (GRCm38)
miRNA Target Status

Expression


Sequence

Nucleotide Sequences
Protein Sequences
Promoters

Additional Information

External Database Links
 
More on Saa2
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: mm9 mm10
MGI Report
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1618412
Created: 2007-05-01
Species: Mus musculus
Last Modified: 2020-09-09
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.